Friday, January 01, 2021 9:31:10 AM
Company has created genetic risk assessment tests for: breast cancer, colorectal cancer, COVID, cardiovascular diseases, Lynch Syndrome, Depression, melanoma and prostate cancer.
Company tests cover hereditary and non-hereditary components, making it unique on the market.
Company has a 2 year cash runway.
Company has research collaborations with some of the most prestigious institutions in the world including: Cambridge University, Harvard Nurses Health, Ohio State University, Translational Genomics Research Institute and Memorial Sloan Kettering.
Company is pursuing direct to consumer model and has begun selling via online health care portals in the US.
GENOMIC sequencing is the new hot area, largely sparked by Cathie Wood of Ark Investments stating this area is where she will find her NEXT TESLA.
PT $20 near term.
Recent GENE News
- Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on October 2 • GlobeNewswire Inc. • 09/23/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/11/2024 01:47:59 PM
- Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics • GlobeNewswire Inc. • 09/11/2024 12:15:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/28/2024 12:15:07 PM
- Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platform • GlobeNewswire Inc. • 08/15/2024 12:00:00 PM
- Join Genetic Technology’s Exclusive Live Investor Webinar and Q&A Session on August 15 • GlobeNewswire Inc. • 08/09/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/31/2024 12:00:33 PM
- Genetic Technologies Strategic Restructure Driving USA Sales Growth • GlobeNewswire Inc. • 07/26/2024 12:00:00 PM
- Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary • GlobeNewswire Inc. • 07/16/2024 12:00:00 PM
- GeneType to Enter Canadian and New Zealand Markets • GlobeNewswire Inc. • 07/09/2024 12:00:00 PM
- GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease • GlobeNewswire Inc. • 06/25/2024 12:00:00 PM
- Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27 • GlobeNewswire Inc. • 06/21/2024 12:00:00 PM
- Genetic Technologies Expands Operational Capacity in North America • GlobeNewswire Inc. • 06/18/2024 12:00:00 PM
- GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test • GlobeNewswire Inc. • 06/05/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/05/2024 10:10:06 AM
- GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer • GlobeNewswire Inc. • 05/29/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/29/2024 10:05:16 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/28/2024 04:15:13 AM
- GeneType and Humanise Health host “Know Your Risk” Event • GlobeNewswire Inc. • 05/23/2024 12:00:00 PM
- GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering • GlobeNewswire Inc. • 04/22/2024 07:00:36 PM
- Genetic Technologies Announces $2 Million Registered Direct Offering • GlobeNewswire Inc. • 04/18/2024 04:17:51 PM
- New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes • GlobeNewswire Inc. • 04/17/2024 12:00:00 PM
- GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- GTG to pilot GeneType in Breast Screen centers across the U.S. • GlobeNewswire Inc. • 04/11/2024 12:00:00 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM